Bottom line
How much do FSPHX and HGHAX overlap?
50% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 38.1% of FSPHX's assets and 49.1% of HGHAX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings FSPHX and HGHAX have in common
| Holding | % of FSPHX | % of HGHAX | Overlap |
|---|---|---|---|
| ELI LILLY and CO | 8.03% | 12.03% | 8.03% |
| Danaher Corp | 6.89% | 2.57% | 2.57% |
| JOHNSON and JOHNSON | 4.91% | 6.75% | 4.91% |
| Thermo Fisher Scientific Inc | 4.33% | 1.58% | 1.58% |
| Unitedhealth Group Inc | 3.49% | 4.74% | 3.49% |
| Boston Scientific Corp | 2.17% | 1.88% | 1.88% |
| Abbvie Inc | 2.03% | 4.21% | 2.03% |
| MERCK and CO INC | 1.60% | 6.00% | 1.60% |
| Cvs Health Corp | 1.29% | 2.84% | 1.29% |
| Cencora Inc | 1.14% | 2.46% | 1.14% |
| Agilent Technologies Inc | 1.10% | 1.54% | 1.10% |
| Edwards Lifesciences Corp | 1.09% | 2.48% | 1.09% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FSPHX
- Alnylam Pharmaceuticals Inc — 2.40%
- Gilead Sciences Inc — 2.21%
- Ascendis Pharma A/s — 2.17%
- Fidelity Revere Street Trust — 2.17%
- Ucb Sa — 2.03%
- Bio Techne Corp — 1.70%
- Argenx Se — 1.56%
- Nuvalent Inc — 1.28%
- Natera Inc — 1.27%
- Brightspring Health Services Inc — 1.23%
- Viatris Inc — 1.20%
- Moderna Inc — 1.18%
- West Pharmaceutical Svcs Inc — 1.12%
Only in HGHAX
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- Vertex Pharmaceuticals Inc — 2.64%
- Regeneron Pharmaceuticals Inc — 2.02%
- HCA Healthcare Inc — 1.88%
- Abbott Laboratories — 1.82%
- Amgen Inc — 1.39%
- Biogen Inc — 1.36%
- Stryker Corp — 1.24%
- Gsk Plc — 1.17%
- Medtronic PLC — 1.12%
- Centene Corp — 1.10%
- Dexcom Inc — 1.01%
Asset mix
| Asset type | FSPHX | HGHAX |
|---|---|---|
| Stocks | 97.7% | 98.1% |
| Cash & short-term funds | 2.4% | 0.9% |
| Preferred stock | 2.0% | — |
| Repurchase agreements | — | 0.4% |
| Bonds | 0.1% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Country mix
| Country | FSPHX | HGHAX |
|---|---|---|
| US | 87.0% | 89.6% |
| GB | 2.1% | 2.4% |
| NL | 2.4% | 1.5% |
| IE | 1.0% | 2.2% |
| DK | 2.2% | 0.8% |
| BE | 2.0% | 0.8% |
| CH | 1.4% | 0.7% |
| KY | 1.4% | 0.5% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do FSPHX and HGHAX overlap?
What stocks do FSPHX and HGHAX have in common?
Should I own both FSPHX and HGHAX?
Which holds more stocks, FSPHX or HGHAX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.